Chronic activation of endothelin B receptors: New model of experimental hypertension

Hypertension

Volumn 50, Issue 3, 2007, Pages 512-518

  Fink, Gregory ^a   Li, Melissa ^a   Lau, Yanny ^a   Osborn, John ^b   Watts, Stephanie ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Endothelin; ETB receptor; Hemodynamics; Salt

Indexed keywords

ENDOTHELIN; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; SARAFOTOXIN S6C; SODIUM; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DIURESIS; EXPERIMENTAL MODEL; HEART OUTPUT MEASUREMENT; HEMODYNAMICS; HYPERTENSION; MALE; NONHUMAN; PLASMA VOLUME; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; SODIUM INTAKE; SODIUM URINE LEVEL; VASCULAR RESISTANCE;

ANIMALS; BLOOD PRESSURE; BLOOD VOLUME; CARDIAC OUTPUT; DISEASE MODELS, ANIMAL; DIURESIS; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIN-1; HEART RATE; HYPERTENSION; MALE; NATRIURESIS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; STROKE VOLUME; SULFONAMIDES; VASCULAR RESISTANCE; VIPER VENOMS;

EID: 34548172512     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.094821     Document Type: Article

References (47)

1. Touyz RM, Schiffrin EL. Role of endothelin in human hypertension. Can J Physiol Pharmacol. 2003;81:533-541.
2. Ohkita M, Wang Y, Nguyen ND, Tsai YH, Williams SC, Wiseman RC, Killen PD, Li S, Yanagisawa M, Gariepy CE. Extrarenal ETB plays a significant role in controlling cardiovascular responses to high dietary sodium in rats. Hypertension. 2005;45:940-946.
3. Quaschning T, Rebhan B, Wunderlich C, Wanner C, Richter CM, Pfab T, Bauer C, Kraemer-Guth A, Galle J, Yanagisawa M, Hocher B. Endothelin B receptor-deficient mice develop endothelial dysfunction independently of salt loading. J Hypertens. 2005;23:979-985.
4. Ohuchi T, Kuwaki T, Ling GY, Dewit D, Ju KH, Onodera M, Cao WH, Yanagisawa M, Kumada M. Elevation of blood pressure by genetic and pharmacological disruption of the ETB receptor in mice. Am J Physiol. 1999;276:R1071-R1077.
5. Honore JC, Fecteau MH, Brochu I, Labonte J, Bkaily G, D'Orleans-Juste P. Concomitant antagonism of endothelial and vascular smooth muscle cell ETB receptors for endothelin induces hypertension in the hamster. Am J Physiol Heart Circ Physiol. 2005;289:H1258-H1264.
6. Fryer RM, Rakestraw PA, Banfor PN, Cox BF, Opgenorth TJ, Reinhart GA. Blood pressure regulation by ETA and ETB receptors in conscious, telemetry-instrumented mice and role of ETA in hypertension produced by selective ETB blockade. Am J Physiol Heart Circ Physiol. 2006;290:H2554-H2559.
7. Reinhart GA, Preusser LC, Burke SE, Wessale JL, Wegner CD, Opgenorth TJ, Cox BF. Hypertension induced by blockade of ET(B) receptors in conscious nonhuman primates: role of ET(B) receptors. Am J Physiol Heart Circ Physiol. 2002;283:H1555-H1561.
8. Gariepy CE, Ohuchi T, Williams SC, Richardson JA, Yanagisawa M. Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest. 2000;105:925-933.
9. Ge Y, Bagnall A, Stricklett PK, Strait K, Webb DJ, Kotelevtsev Y, Kohan DE. Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention. Am J Physiol Renal Physiol. 2006;291:F1274-F1280.
10. Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun. 1994;199:1461-1465.
11. Bagnall AJ, Kelland NF, Gulliver-Sloan F, Davenport AP, Gray GA, Yanagisawa M, Webb DJ, Kotelevtsev YV. Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt. Hypertension. 2006;48:286-293.
12. Quaschning T, Voss F, Relle K, Kalk P, Vignon-Zellweger N, Pfab T, Bauer C, Theilig F, Bachmann S, Kraemer-Guth A, Wanner C, Theuring F, Galle J, Hocher B. Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/ endothelial nitric oxide synthase knockout mice. J Am Soc Nephrol. 2007;18:730-740.
13. Davenport AP, Kuc RE. Down-regulation of ETA receptors in ETB receptor-deficient mice. J Cardiovasc Pharmacol. 2004;44:S276-S278.
14. Williams DL Jr, Jones KL, Pettibone DJ, Lis EV, Clineschmidt BV. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun. 1991;175:556-561.
15. Clozel M, Gray GA, Breu V, Loffler BM, Osterwalder R. The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun. 1992;186:867-873.
16. Sharifi AM, Schiffrin EL. Endothelin receptors mediating vasoconstriction in rat pressurized small arteries. Can J Physiol Pharmacol. 1996;74:934-939.
17. Tschudi MR, Luscher TF. Characterization of contractile endothelin and angiotensin receptors in human resistance arteries: evidence for two endothelin and one angiotensin receptor. Biochem Biophys Res Commun. 1994;204:685-690.
18. Lau YE, Galligan JJ, Kreulen DL, Fink GD. Activation of ETB receptors increases superoxide levels in sympathetic ganglia in vivo. Am J Physiol Regul Integr Comp Physiol. 2006;290:R90-R95.
19. Fine DM, Ariza-Nieto P, Osborn JW. Does whole body autoregulation mediate the hemodynamic responses to increased dietary salt in rats with clamped Ang II? Am J Physiol Heart Circ Physiol. 2003;285:H2670-H2678.
20. Ballew JR, Fink GD. Role of endothelin etb receptor activation in angiotensin II-induced hypertension: effects of salt intake. Am J Physiol Heart Circ Physiol. 2001;281:H2218-H2225.
21. Wang H, Chen AF, Watts SW, Galligan JJ, Fink GD. Endothelin in the splanchnic vascular bed of DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol. 2005;288:H729-H736.
22. Mortensen LH, Pawloski CM, Kanagy NL, Fink GD. Chronic hypertension produced by infusion of endothelin in rats. Hypertension. 1990;15:729-733.
23. Mortensen LH, Fink GD. Salt-dependency of endothelin-induced, chronic hypertension in conscious rats. Hypertension. 1992;19:549-554.
24. Wessale JL, Adler AL, Novosad EI, Calzadilla SV, Dayton BD, Marsh KC, Winn M, Jae HS, von Geldern TW, Opgenorth TJ, Wu-Wong JR. Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: ex vivo and in vivo studies. Clin Sci (Lond). 2002;103:112S-117S.
25. Ballew JR, Fink GD. Role of ET(A) receptors in experimental Ang II-induced hypertension in rats. Am J Physiol Regul Integr Comp Physiol. 2001;281:R150-R154.
26. Flynn DA, Sargent CA, Brazdil R, Brown TJ, Roach AG. Sarafotoxin s6c elicits a non-ETA or non-ETB-mediated pressor response in the pithed rat. J Cardiovasc Pharmacol. 1995;26:S219-S221.
27. Krause SM, Nolan NA, Clayton FC, Walsh TF, Williams DL Jr. Characterization of endothelin receptors in the anesthetized ferret: a novel model for investigating the functional ET(B) receptor subtypes. J Cardiovasc Pharmacol. 1999;34:359-367.
28. Williams JM, Pollock JS, Pollock DM. Arterial pressure response to the antioxidant tempol and ETB receptor blockade in rats on a high-salt diet. Hypertension. 2004;44:770-775.
29. Granger JP, Abram S, Stec D, Chandler D, LaMarca B. Endothelin, the kidney, and hypertension. Curr Hypertens Rep. 2006;8:298-303.
30. Brooks DP, DePalma PD, Pullen M, Gellai M, Nambi P. Identification and function of putative ETB receptor subtypes in the dog kidney. J Cardiovasc Pharmacol. 1995;26:S322-S325.
31. Gellai M, Fletcher T, Pullen M, Nambi P. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat. Am J Physiol. 1996;271:R254-R261.
32. Just A, Olson AJ, Arendshorst WJ. Dual constrictor and dilator actions of ET(B) receptors in the rat renal microcirculation: interactions with ET(A) receptors. Am J Physiol Renal Physiol. 2004;286:F660-F668.
33. Adner M, Geary GG, Edvinsson L. Appearance of contractile endothelin-B receptors in rat mesenteric arterial segments following organ culture. Acta Physiol Scand. 1998;163:121-129.
34. Adner M, Uddman E, Cardell LO, Edvinsson L. Regional variation in appearance of vascular contractile endothelin-B receptors following organ culture. Cardiovasc Res. 1998;37:254-262.
35. Claing A, Shbaklo H, Plante M, Bkaily G, D'Orleans-Juste P. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein. Br J Pharmacol. 2002;135:433-443.
36. Haynes WG, Strachan FE, Webb DJ. Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation. 1995;92:357-363.
37. Pollock DM, Portik-Dobos V, Procter C, Gariepy CE, Yanagisawa M. Arterial pressure response to endothelin-1 and sarafotoxin 6c in rescued endothelin-B-deficient rats. J Cardiovasc Pharmacol. 2000;36:S82-S85.
38. Tyberg JV. How changes in venous capacitance modulate cardiac output. Pflugers Arch. 2002;445:10-17.
39. Moreland S, McMullen D, Abboa-Offei B, Seymour A. Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature. Br J Pharmacol. 1994;112:704-708.
40. Lodge NJ, Zhang R, Halaka NN, Moreland S. Functional role of endothelin ETB and ETA receptors in venous and arterial smooth muscle. Eur J Pharmacol. 1995;287:279-285.
41. Chobanian AV, Tifft CP, Faxon DP, Creager MA, Sackel H. Treatment of chronic orthostatic hypotension with ergotamine. Circulation. 1983;67:602-609.
42. Bevegard S, Castenfors J, Lindblad LE. Circulatory effects of dihydroergotamine in patients with disturbed sympathetic vasomotor control with special reference to postural hypotension. Cardiology. 1976;61:322-332.
43. Uchiyama M, Sakai K. Urinary electrolyte excretion and orthostatic response of blood pressure and plasma renin activity in children with postural hypotension before and after treatment with dihydergot. J Int Med Res. 1985;13:54-58.
44. Ward CR, Gray JC, Gilroy JJ, Kenny RA. Midodrine: a role in the management of neurocardiogenic syncope. Heart. 1998;79:45-49.
45. Denq JC, Opfer-Gehrking TL, Giuliani M, Felten J, Convertino VA, Low PA. Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension. Clin Auton Res. 1997;7:321-326.
46. Bloomfield GL, Sugerman HJ, Blocher CR, Gehr TW, Sica DA. Chronically increased intra-abdominal pressure produces systemic hypertension in dogs. Int J Obes Relat Metab Disord. 2000;24:819-824.
47. Sonkusare S, Palade PT, Marsh JD, Telemaque S, Pesic A, Rusch NJ. Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications. Vascul Pharmacol. 2006;44:131-142.